Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
TherapeuticsMD
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
TherapeuticsMD, Inc.
PR-M09-18-NI-002
Sep 04, 2018
Treatment
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for Treatment
TherapeuticsMD, Inc.
PR-M06-18-NI-006
Jun 04, 2018
